Economic Evaluation of Human Rotavirus Vaccine in Thailand
Open Access
- 13 June 2019
- journal article
- research article
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 8 (3) , 397-415
Abstract
Rotavirus gastroenteritis is the leading cause of severe diarrhoea among young children < 5 years old. Previous cost-effectiveness analyses on rotavirus (RV) vaccination in Thailand have generated conflicting results. The aim of this current study is to evaluate the economic impact of introducing RV vaccination in Thailand, using updated Thai epidemiological and cost data.Keywords
Funding Information
- GlaxoSmithKline Biologicals SA
This publication has 35 references indexed in Scilit:
- Cost-effectiveness of pharmacist-participated warfarin therapy management in ThailandThrombosis Research, 2013
- Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced modelVaccine, 2013
- Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian populationVaccine, 2012
- Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in ThailandVaccine, 2012
- Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: A systematic reviewVaccine, 2012
- Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United StatesVaccine, 2011
- The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the NetherlandsVaccine, 2008
- Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspectiveArchives of Disease in Childhood, 2008
- Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus GastroenteritisNew England Journal of Medicine, 2006
- Epidemiology and Burden of Rotavirus Diarrhea in Thailand: Results of Sentinel SurveillanceThe Journal of Infectious Diseases, 2005